Schedule of Revision in Financial Statements |
The
table below present the impact of the revision in the Company’s condensed consolidated financial statements.
Schedule
of Revision in Financial Statements
|
|
As
Previously Reported |
|
|
Adjustment |
|
|
As
Revised |
|
|
|
December
31, 2021 |
|
|
|
As
Previously Reported |
|
|
Adjustment |
|
|
As
Revised |
|
|
|
|
|
|
|
|
|
|
|
Consolidated
Balance Sheet / Statement of Changes in Stockholders’ Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
deficit |
|
$ |
(4,138,526 |
) |
|
$ |
(66,650 |
) |
|
$ |
(4,205,176 |
) |
Non-controlling
interest |
|
$ |
(66,650 |
) |
|
$ |
66,650 |
|
|
$ |
- |
|
Total
Stockholders’ Deficit |
|
$ |
(3,392,961 |
) |
|
$ |
- |
|
|
$ |
(3,392,961 |
) |
Total
Liabilities and Stockholders’ Deficit |
|
$ |
1,014,551 |
|
|
$ |
- |
|
|
$ |
1,014,551 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
Statement of Operations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain
on deconsolidation of Krypto Ventures, Inc. |
|
$ |
153,907 |
|
|
$ |
(66,650 |
) |
|
$ |
87,257 |
|
Total
other expense |
|
$ |
(1,033,830 |
) |
|
$ |
(66,650 |
) |
|
$ |
(1,100,480 |
) |
Net
(Loss) Income |
|
$ |
(809,404 |
) |
|
$ |
(66,650 |
) |
|
$ |
(876,054 |
) |
Net
(Loss) Income attributable to the Company |
|
$ |
(796,696 |
) |
|
$ |
(66,650 |
) |
|
$ |
(863,346 |
) |
Net
(Loss) Income per share - basic |
|
$ |
(0.04 |
) |
|
$ |
- |
|
|
$ |
(0.04 |
) |
Net
(Loss) Income per share - diluted |
|
$ |
(0.04 |
) |
|
$ |
-
|
|
|
$ |
(0.04 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
Statement of Cash Flows |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
activities |
|
|
|
|
|
|
|
|
|
|
|
|
Net
(Loss) Income - including non-controlling interest |
|
$ |
(809,404 |
) |
|
$ |
(66,650 |
) |
|
$ |
(876,054 |
) |
Gain
on deconsolidation of subsidiary (Krypto Ventures, Inc.) |
|
$ |
153,907 |
|
|
$ |
(66,650 |
) |
|
$ |
87,257 |
|
Net
cash used in operating activities |
|
$ |
(56,896 |
) |
|
$ |
- |
|
|
$ |
(56,896 |
) |
|